SecBot SecBot
6-K ·Filed Nov 5, 2026

NVO

NOVO NORDISK A S
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 14h ago SEC0001171843-26-007156
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine disclosure of an insider share sale. No material read-through for the company's operations or outlook. Monitor for any pattern of increased insider selling in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$40.30
T+0 close · Nov 5, 2026 · via day close
Latest settled
+0.87%
T+5 · $40.65
Vs SPY
−2.42%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $40.30entry
  2. T+1 · 11d ago +0.02%α −0.29% · $40.31
  3. T+5 · 5d ago +0.87%α −2.42% · $40.65
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Novo Nordisk filed a Form 6-K disclosing a share sale by Executive Vice President and CSO Martin Holst Lange. He sold 12,000 B shares at DKK 285.00 per share, for a total of DKK 3,420,000. This is a routine insider sale disclosure with no material financial impact.

Key Facts

  • Martin Holst Lange (EVP, R&D and CSO) sold 12,000 Novo Nordisk B shares
  • Sale price: DKK 285.00 per share
  • Total proceeds: DKK 3,420,000
  • Transaction date: November 4, 2026
  • Place of transaction: Nasdaq Copenhagen

Financial Impact

DKK 3.42 million insider sale by a single executive

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
28% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-007156
Document: 0001171843-26-007156-index-headers.html0001171843-26-007156
Document: 0001171843-26-007156-index.html0001171843-26-007156
Document: 0001171843-26-007156.txt0001171843-26-007156
Earnings Context (Synthetic; results releases only)0001171843-26-007156

Track record

43 reports on NVO

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +23.56% at T+60 after the Jul 28, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Neutral 2/10 Entry $41.89 Now $41.60 −0.69% settles Dec 15
  2. Nov 13, 20264d ago Court Ruling Neutral 3/10 Entry $42.01 Now $41.60 −0.98% settles Dec 15
  3. Nov 13, 20264d ago Court Ruling Neutral 1/10 Entry $42.01 Now $41.60 −0.98% settles Dec 15
  4. Nov 9, 20267d ago 6-K Neutral 2/10 Entry $41.38 Now $41.60 +0.53% settles Dec 8
  5. Nov 5, 202611d ago Institutional Cluster Neutral 2/10 Entry $40.30 Now $41.60 +3.23% settles Dec 4
  6. Nov 5, 202611d ago 6-K Neutral 2/10 Viewing Entry $40.30 Now $41.60 +3.23% settles Dec 4
  7. Nov 4, 202612d ago 6-K Bullish 6/10 Entry $42.18 Now $41.60 −1.38% settles Dec 3
  8. Nov 3, 202613d ago 6-K Neutral 2/10 Entry $40.19 Now $41.60 +3.51% settles Dec 2
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $39.13 Now $41.60 +6.31% settles Nov 23
  10. Oct 26, 202622d ago Court Ruling Neutral 4/10 Entry $38.67 Now $41.60 +7.58% settles Nov 24
Showing 10 of 43

US Market Status

Market Closed · Opens in 5h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026